INDIANAPOLIS, Aug. 13, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today Taltz® (ixekizumab) met the primary and all major secondary endpoints up to week 12 in the Phase 4 IXORA-R study, which evaluated the efficacy and safety of Taltz versus TREMFYA® (guselkumab) in people living with moderate to severe plaque psor

BOSTON, Aug. 13, 2019 /PRNewswire/ -- Seven Bridges, the industry-leading bioinformatics solution provider, today announced plans to expand operations into Novi Sad, Serbia in support of their growing customer base and to expedite product innovation.

NEW YORK and CAESAREA, Israel, Aug. 13, 2019 /PRNewswire/ -- Q2 2019 Revenue of $1.65 million, a 20% decline from Q2 2018 Record 1H 2019 Revenue of $3.89 million, a 2% increase over 1H 2018 Expense shift from D2C to

BALTIMORE, Aug. 13, 2019 /PRNewswire/ -- New research, published today in the flagship journal of the American Society for Microbiology, is the first to identify a specific mechanism by which keystone species of bacteria in the vaginal microbiome affect a woman's susceptibility to sexually transmitted infections.The research is timely amidst a rising number of sex

SAN DIEGO, Aug. 13, 2019 /PRNewswire/ -- GraphPad

RESEARCH TRIANGLE PARK, N.C., Aug. 13, 2019 /PRNewswire/ -- AskBio, the world's foremost clinical stage and gene therapy platform company, has acquired

SUZHOU, China, Aug. 13, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announces the dosing of the first patient in China for the Phase I registrational study of BLU-667, which was discovered by the company's partner Blueprint Medicines. This clinical trial is a part of the ongoing, global Phase I ARROW trial tha

TEGUCIGALPA, Honduras, Aug. 12, 2019 /PRNewswire/ -- The government of the Republic of Honduras announced to the national and international community: Honduras President, Juan Orlando Hernández, and members of his cabinet will travel to Washington DC, to participa

BRENTWOOD, Tenn., Aug. 12, 2019 /PRNewswire/ -- AAC Holdings, Inc. (NYSE: AAC) (the "Company") announced preliminary estimated operational and financial results for the second quarter ended June 30, 2019. Second Quarter 2019 Highlights: (All comparisons are to first quarter ended March 31, 2019, unless ot

ARLINGTON, Va., Aug. 12, 2019 /PRNewswire/ -- March of Dimes released the following statement from Stacey D. Stewart, President and CEO, in response to the Administration's action today finalizing the rule on the circumstances under which immigrants could be considered a "public charge," thereby endangering their immigration status. Ma